Prostatype Genomics (Sweden) Performance

Prostatype Genomics Relative Risk vs. Return Landscape

If you would invest  66.00  in Prostatype Genomics AB on October 31, 2025 and sell it today you would earn a total of  107.00  from holding Prostatype Genomics AB or generate 162.12% return on investment over 90 days. Prostatype Genomics AB is generating 2.6627% of daily returns and assumes 15.0233% volatility on return distribution over the 90 days horizon. Simply put, majority of traded equity instruments are less risky than Prostatype on the basis of their historical return distribution, and most equity instruments are likely to generate higher returns than the company over the next 90 trading days.Assuming the 90 days trading horizon Prostatype Genomics is expected to generate 19.9 times more return on investment than the market. However, the company is 19.9 times more volatile than its market benchmark. It trades about 0.18 of its potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.07 per unit of risk.

Prostatype Genomics Target Price Odds to finish over Current Price

Assuming the 90 days trading horizon Prostatype Genomics AB has a beta of -0.43 indicating as returns on the benchmark increase, returns on holding Prostatype Genomics are expected to decrease at a much lower rate. During a bear market, however, Prostatype Genomics AB is likely to outperform the market. In addition to that Prostatype Genomics AB has an alpha of 2.2827, implying that it can generate a 2.28 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).

Predictive Modules for Prostatype Genomics

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Prostatype Genomics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.

Hype Prediction Low Estimated High 0.09 1.73 16.63 Details

Intrinsic Valuation Low Real High 0.06 1.20 16.10 Details

Naive Forecast Low Next High 0.04 2.01 16.91 Details

Bollinger Band Projection (param) Lower Middle Band Upper -0.18 0.92 2.03 Details

Prostatype Genomics Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Prostatype Genomics is not an exception. The market had few large corrections towards the Prostatype Genomics' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Prostatype Genomics AB, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Prostatype Genomics within the framework of very fundamental risk indicators.

Prostatype Genomics Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Prostatype Genomics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Prostatype Genomics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.

Prostatype Genomics Fundamentals Growth

When running Prostatype Genomics' price analysis, check to measure Prostatype Genomics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Prostatype Genomics is operating at the current time. Most of Prostatype Genomics' value examination focuses on studying past and present price action to predict the probability of Prostatype Genomics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Prostatype Genomics' price. Additionally, you may evaluate how the addition of Prostatype Genomics to your portfolios can decrease your overall portfolio volatility.